Prostate Cancer - Results from #24680

Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer - Abstract November 20, 2012

The potential of circulating tumor cells as a liquid biopsy to guide therapy in prostate cancer - Abstract November 20, 2012

Challenging the 10-year rule: The accuracy of patient life expectancy predictions by physicians in relation to prostate cancer management - Abstract November 20, 2012

Efficacy versus effectiveness study design within the European screening trial for prostate cancer: Consequences for cancer incidence, overall mortality and cancer-specific mortality - Abstract November 20, 2012

Anti-angiogenic therapies in prostate cancer - Abstract November 20, 2012

Partial sampling of radical prostatectomy specimens: Detection of positive margins and extraprostatic extension - Abstract November 20, 2012

Prospective study on metabolic factors and risk of prostate cancer - Abstract November 20, 2012

Androgen metabolism gene polymorphisms, associations with prostate cancer risk and pathological characteristics: A comparative analysis between South African and Senegalese men - Abstract November 20, 2012

Association of obesity and diabetes with serum prostate-specific antigen levels in Japanese males - Abstract November 20, 2012

The REDUCE metagram: A comprehensive prediction tool for determining the utility of dutasteride chemoprevention in men at risk for prostate cancer - Abstract November 19, 2012

Low incidence of fatigue after hypofractionated stereotactic body radiation therapy for localized prostate cancer - Abstract November 19, 2012

Geometric evaluation of systematic transrectal ultrasound guided prostate biopsy - Abstract November 19, 2012

Complications of laparoscopic radical prostatectomy-a single institute experience - Abstract November 19, 2012

Strength training induces muscle hypertrophy and functional gains in Black prostate cancer patients despite androgen deprivation therapy - Abstract November 19, 2012

Cabazitaxel: More than a new taxane for metastatic castrate-resistant prostate cancer? - Abstract November 19, 2012

Management of docetaxel failures in metastatic castrate-resistant prostate cancer - Abstract November 16, 2012

Targeted therapies in metastatic castration-resistant prostate cancer: Beyond the androgen receptor - Abstract November 16, 2012

Bone-targeted agents: Preventing skeletal complications in prostate cancer - Abstract November 16, 2012

Advanced clinical states in prostate cancer - Abstract November 16, 2012

The experience with cytotoxic chemotherapy in metastatic castration-resistant prostate cancer - Abstract November 16, 2012

Page 1235 of 1451